Clinical implication of protease-activated receptor-2 in idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 107, Issue 2, 2013, Pages 256-262

  Park, Young Sik ^a   Park, Chang Min ^b   Lee, Hyun Ju ^b   Goo, Jin Mo ^b   Chung, Doo Hyun ^b   Lee, Sang Min ^a   Yim, Jae Joon ^a   Kim, Young Whan ^a   Han, Sung Koo ^a   Yoo, Chul Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Honeycombing; Idiopathic pulmonary fibrosis; Mortality; Protease activated receptor

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2;

ARTICLE; CLINICAL FEATURE; EPITHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG SURGERY; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LUNG; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, PAR-2; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84872102581     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.10.011     Document Type: Article

References (31)

1. S. Harari, and A. Caminati Idiopathic pulmonary fibrosis Allergy 60 2005 421 435
2. A. Caminati, and S. Harari IPF: new insight in diagnosis and prognosis Respir Med 104 Suppl. 1 2010 S2 S10
3. M. Selman, T. King, and A. Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2001 136 151
4. J. Gauldie Pro: inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 165 2002 1205 1206
5. R.C. Chambers Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol 153 Suppl. 1 2008 S367 S378
6. K. Borensztajn, J. Stiekema, S. Nijmeijer, P.H. Reitsma, M.P. Peppelenbosch, and C.A. Spek Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation Am J Pathol 172 2008 309 320
7. K. Borensztajn, P. Bresser, C. van der Loos, I. Bot, B. van den Blink, and M.A. den Bakker Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis Am J Pathol 177 2010 2753 2764
8. S. Nystedt, K. Emilsson, C. Wahlestedt, and J. Sundelin Molecular cloning of a potential proteinase activated receptor Proc Natl Acad Sci U S A 91 1994 9208 9212
9. S. Nystedt, K. Emilsson, A.K. Larsson, B. Strombeck, and J. Sundelin Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2 Eur J Biochem 232 1995 84 89
10. M. D'Andrea, C. Derian, D. Leturcq, S. Baker, A. Brunmark, and P. Ling Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues J Histochem Cytochem 46 1998 157 164
11. D. Miotto, M. Hollenberg, N. Bunnett, A. Papi, F. Braccioni, and P. Boschetto Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers Thorax 57 2002 146 151
12. H. Vliagoftis, A.D. Befus, M.D. Hollenberg, and R. Moqbel Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2 J Allergy Clin Immunol 107 2001 679 685
13. T. Peters, and P. Henry Protease-activated receptors and prostaglandins in inflammatory lung disease Br J Pharmacol 158 2009 1017 1033
14. M. Wygrecka, G. Kwapiszewska, E. Jablonska, S. von Gerlach, I. Henneke, and D. Zakrzewicz Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 2011 1703 1714
15. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
16. T. Ashcroft, J.M. Simpson, and V. Timbrell Simple method of estimating severity of pulmonary fibrosis on a numerical scale J Clin Pathol 41 1988 467 470
17. M. Akira, M. Sakatani, and E. Ueda Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT Radiology 189 1993 687 691
18. L. Dastgheib, A. Monabati, A. Mohammadian, F. Sari-Aslani, S. Marzban, and M.R. Namazi Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin J Cutan Pathol 36 2009 314 317
19. S. Imokawa, A. Sato, H. Hayakawa, M. Kotani, T. Urano, and A. Takada Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis Am J Respir Crit Care Med 156 1997 631 636
20. A. Gunther, P. Mosavi, S. Heinemann, C. Ruppert, H. Muth, and P. Markart Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome Am J Respir Crit Care Med 161 2000 454 462
21. A. Masamune, K. Kikuta, M. Satoh, N. Suzuki, and T. Shimosegawa Protease-activated receptor-2-mediated proliferation and collagen production of rat pancreatic stellate cells J Pharmacol Exp Ther 312 2005 651 658
22. J. Xiong, Z. Zhu, J. Liu, Y. Wang, and Z. Li Role of protease activated receptor-2 expression in renal interstitial fibrosis model in mice J Huazhong Univ Sci Technolog Med Sci 25 2005 523 526
23. K. Borensztajn, J.H. von der Thusen, M.P. Peppelenbosch, and C.A. Spek The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm J Cell Mol Med 14 2010 143 153
24. D. Knight, S. Lim, A. Scaffidi, N. Roche, K. Chung, and G. Stewart Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma J Allergy Clin Immunol 108 2001 797 803
25. N. Roche, R. Stirling, S. Lim, B. Oliver, T. Oates, and E. Jazrawi Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages J Allergy Clin Immunol 111 2003 367 373
26. U. Costabel, and J. Guzman Bronchoalveolar lavage in interstitial lung disease Curr Opin Pulm Med 7 2001 255 261
27. E.R. Parra, R.A. Kairalla, C.R. Ribeiro de Carvalho, E. Eher, and V.L. Capelozzi Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia Respiration 74 2007 159 169
28. G. Ramelli, S. Fuertes, S. Narayan, N. Busso, H. Acha-Orbea, and A. So Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo Immunology 129 2010 20 27
29. D. Boveda-Ruiz, C.N. D'Alessandro-Gabazza, M. Toda, T. Takagi, M. Naito, and Y. Matsushima Differential role of regulatory T cells in early and late stages of pulmonary fibrosis Immunobiology 2012
30. I.G. Luzina, N.W. Todd, A.T. Iacono, and S.P. Atamas Roles of T lymphocytes in pulmonary fibrosis J Leukoc Biol 83 2008 237 244
31. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, and K.K. Brown An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824